Skip to content

Independent register of U.S. FDA drug recalls · updated Oct 10, 2026

FDA Drug Recalls

14,806 recalls, newest first

Dec 30, 2022 Class II · Moderate risk

Prostaglandin

Lack of Assurance of Sterility

Terminated Sterility / contamination Northern VA Compounders PLLC D-0110-2023

Dec 30, 2022 Class II · Moderate risk

Prostaglandin

Lack of Assurance of Sterility

Terminated Sterility / contamination Northern VA Compounders PLLC D-0109-2023

Dec 30, 2022 Class II · Moderate risk

QuadMix Super 002

Lack of Assurance of Sterility

Terminated Sterility / contamination Northern VA Compounders PLLC D-0108-2023

Dec 30, 2022 Class II · Moderate risk

QuadMix Standard 001

Lack of Assurance of Sterility

Terminated Sterility / contamination Northern VA Compounders PLLC D-0107-2023

Dec 30, 2022 Class II · Moderate risk

TriMix Original

Lack of Assurance of Sterility

Terminated Sterility / contamination Northern VA Compounders PLLC D-0106-2023

Dec 30, 2022 Class II · Moderate risk

QuadMix Super 001

Lack of Assurance of Sterility

Terminated Sterility / contamination Northern VA Compounders PLLC D-0105-2023

Dec 30, 2022 Class II · Moderate risk

QuadMix Standard 002

Lack of Assurance of Sterility

Terminated Sterility / contamination Northern VA Compounders PLLC D-0104-2023

Dec 30, 2022 Class II · Moderate risk

QuadMix Plus

Lack of Assurance of Sterility

Terminated Sterility / contamination Northern VA Compounders PLLC D-0103-2023

Dec 30, 2022 Class II · Moderate risk

Mitomycin Injection Solution

Lack of Assurance of Sterility

Terminated Sterility / contamination Northern VA Compounders PLLC D-0102-2023

Dec 28, 2022 Class II · Moderate risk

Rasagiline Mesylate Tablets 1 mg

Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.

Terminated Particulate / foreign matter Ascend Laboratories, LLC NDC 67877-260-30 D-0159-2023

Dec 27, 2022 Class II · Moderate risk

BuPROPion Hydrochloride Tablets

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation Amerisource Health Services LLC D-0328-2023

Dec 27, 2022 Class II · Moderate risk

VITAMIN K (Phytonadione)

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0324-2023

Dec 27, 2022 Class II · Moderate risk

Vancomycin

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0323-2023

Dec 27, 2022 Class II · Moderate risk

Vancomycin

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0322-2023

Dec 27, 2022 Class II · Moderate risk

TPN (a) 95GM/AA, 385/DEX, 50GM/LIP 1800ML, (b)TPN AA:100GM…

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0321-2023

Dec 27, 2022 Class II · Moderate risk

TPN (a) 115GM/AA, 215GM/DEX, 25GM/LIP 1150ML, (b)90GM/AA…

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0320-2023

Dec 27, 2022 Class II · Moderate risk

TPN 107gm/AA

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0319-2023

Dec 27, 2022 Class II · Moderate risk

TPN (a) 100GM/AA, 285GM/DEX, (b)55GM/LIP 2300ML, (c)55GM/AA…

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0318-2023

Dec 27, 2022 Class II · Moderate risk

Tobramycin 660mg in Ns 66ml

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0317-2023

Dec 27, 2022 Class II · Moderate risk

Sodium Chloride 0.9 %

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0316-2023

Dec 27, 2022 Class II · Moderate risk

Piperacillin / Tazobactam

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0315-2023

Dec 27, 2022 Class II · Moderate risk

Penicillin

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0314-2023

Dec 27, 2022 Class II · Moderate risk

Pantoprazole 30mg in Ns 7.5ml

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0313-2023

Dec 27, 2022 Class II · Moderate risk

Ondansetron 8mg in Ns 100ml

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0312-2023

Dec 27, 2022 Class II · Moderate risk

Nalbuphine

Lack of sterility assurance

Terminated Sterility / contamination Sentara Infusion Services D-0311-2023

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061